Abstract
(1). We investigated the effects of inhibiting d-amino-acid oxidase (DAO) activity on nociceptive responses through the use of mutant ddY/DAO− mice, which lack DAO activity, and through the application of a selective inhibitor of DAO, sodium benzoate, in the tail flick test, hot-plate test, formalin test, and acetic acid-induced writhing test. (2). Compared with normal ddY/DAO+ mice, ddY/DAO− mice showed significantly prolonged tail withdrawal latency in the tail flick test and licking/jumping latency in the hot-plate test, as well as significantly reduced duration of licking/biting in the late phase of the formalin test and the number of abdominal writhing in the acetic acid-induced writhing test. (3). In addition, we investigated the effects of sodium benzoate in Kunming mice having normal DAO activity. (4). Intravenous administration of sodium benzoate (400 mg/kg) significantly inhibited pain responses of the late phase of the formalin test and abdominal writhing responses in the acetic acid-induced writhing test, with no effects on the early phase flinch responses in the formalin test, nociceptive responses in the tail flick test, or hot-plate test. (5). These results suggest that DAO acts as a pro-nociceptive factor in pain, particularly chronic pain, transmission and modulation, and may be a target for pain treatment.
Similar content being viewed by others
References
D’Aniello A, D’Onofrio G, Pischetola M, D’Aniello G, Vetere A, Petrucelli L, Fisher GH (1993) Biological role of d-amino acid oxidase and d-aspartate oxidase, effects of d-amino acids. J Biol Chem 268:26941–26949
D’Silva C, Williams CH Jr, Massey V (1986) Electrophilic amination of a single methionine residue located at the active site of d-amino acid oxidase by O-(2,4-dinitrophenyl) hydroxylamine. Biochemistry 25:5602–5608
Fang QK, Hopkins S, Jones S, Fang Q (2005) New pyrazole derivatives, useful to e.g. treat ataxia, schizophrenia ands neuropathic pain, are d-amino acid oxidase inhibitors. Patent Number(s): WO2005066135-A2; US2005143443-A1; EP1709004-A2; CZ200600427-A3
Hashimoto A, Nishikawa T, Konno R, Niwa A, Yasumura Y, Oka T, Takahashi K (1993a) Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci Lett 152:33–36
Hashimoto A, Nishikawa T, Oka T, Takahashi K (1993b) Endogenous dD-serine in rat: N-methyl-d-aspartate receptor-related distribution and aging. J Neurochem 60:783–786
Hashimoto A, Nishikawa T, Hayashi T, Fujii N, Harada K, Oka T, Takahashi K (1992) The presence of free d-serine in rat brain. FEBS Lett 296:33–36
Horiike K, Tojo H, Arai R, Nozaki M, Maeda T (1994) d-Amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res 652:297–303
Konno R, Yasumura Y (1992) d-Amino-acid oxidase and its physiological function. Int J Biochem 24:519–524
Konno R, Yasumura Y (1983) Mouse mutant deficient in d-amino acid oxidase activity. Genetics 103:277–285
Kappor R, Kapoor V (1997) Distribution of Dd-amino acid oxidase (DAO) activity in the medulla and thoracic spinal cord of the rat: implications for a role for d-serine in autonomic function. Brain Res 771:351–355
London RE, Gabel SA (1988) A deuterium surface coil NMR study of the metabolism of d-methionine in the liver of the anesthetized rat. Biochemistry 27:7864–7869
Matsui T, Sekiguchi M, Hashimoto A, Tomita U, Nishikawa T, Wada K (1995) Functional comparison of d-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem 65:454–458
Moses J, Siddiqui A, Silverman PB (1996) Sodium benzoate differentially blocks circling induced by d- and l-dopa in the hemiparkinsonian rat. Neurosci Lett 218:145–148
Sasaki M, Konno R, Nishio M, Niwa A, Yasumura Y, Enami J (1992) A single-base-pair substitution abolishes d-amino-acid oxidase activity in the mouse. Biochim Biophys Acta 1139:315–318
Schell MJ, Molliver ME, Snyder SH (1995) d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92:3948–3952
Schell MJ, Brady RO Jr, Molliver ME, Snyder SH (1997) d-Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci 17:1604–1615
Wake K, Yamazaki H, Hanzawa S, Konno R, Sakio H, Niwa A, Hori Y (2001) Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking Dd-amino-acid oxidase. Neurosci Lett 297:25–28
Wang YX, Gao D, Pettus M, Phillips C, Bowersox SS (2000) Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Pain 84:271–281
Williams RE, Lock EA (2005) Sodium benzoate attenuates d-serine induced nephrotoxicity in the rat. Toxicology 207:35–48
Xin YF, Zhou XJ, Lu J, Wang YX (2007) Inhibitory effects of benzoate on chiral inversion and clearance of N(G)-nitro-arginine in conscious rats. Drug Metab Dispos 35:331–334
Yasuda E, Ma N, Semba R (2001) Immunohistochemical evidences for localization and production of d-serine in some neurons in the rat brain. Neurosci Lett 299:162–164
Yoshikawa M, Oka T, Kawaguchi M, Hashimoto A (2004) MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain. Mol Brain Res 131:141–144
Acknowledgment
Konno was supported by a grant from the Asahi Glass Foundation, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, W., Konno, R., Zhou, XJ. et al. Inhibition of d-Amino-Acid Oxidase Activity Induces Pain Relief in Mice. Cell Mol Neurobiol 28, 581–591 (2008). https://doi.org/10.1007/s10571-007-9200-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-007-9200-y